The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Traumatic brain injury (TBI) leads to neuropathology via immediate and secondary injury mechanisms.
• Chronic neuroinflammation, driven by unresolved glial activation post-TBI, contributes to long-term deficits.
• p38α MAPK signaling in microglia is crucial for cytokine production and inflammatory neuronal dysfunction.

Purpose of the Study:

• To investigate the role of the p38α signaling pathway in microglia in secondary neuropathology following diffuse TBI.
• To determine if p38α deficiency in microglia impacts TBI-induced motor deficits and synaptic integrity.

Main Methods:

• Utilized a mouse model of diffuse TBI.
• Compared wild-type (WT) mice with microglia-specific p38α-deficient (p38α KO) mice.
• Assessed motor function, synaptic protein loss, microglia activation, and cytokine/chemokine levels at various time points post-TBI.

Main Results:

• p38α KO mice showed protection against TBI-induced motor deficits and synaptic protein loss.
• Diffuse TBI induced sustained microglia activation in WT mice, which was absent in p38α KO mice.
• Initially, p38α KO mice exhibited increased acute cytokine and chemokine levels post-TBI, but these normalized by 7 days, unlike in WT mice.

Conclusions:

• p38α signaling in microglia plays a dual role in TBI neuropathology.
• It acutely attenuates early pro-inflammatory cytokine surges while perpetuating chronic microglia activation and neuroinflammation.
• Targeting p38α in microglia may offer therapeutic potential for mitigating chronic TBI sequelae.